跳至主要内容
临床试验/CTRI/2024/10/074906
CTRI/2024/10/074906尚未招募不适用

Hyperbaric spinal Anaesthesia with Bupivacaine 0.25 percent for urological procedures.

GSVM1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年10月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Effective sensory block ( onset and duration)

研究概览

简要总结

To use bupivacaine 0.25 % in lower urological procedures.

 a)       Primary aim: Effective sensory block ( onset and duration)

Effective motor block ( onset and duration)

Hemodynamic stability

 b)      Secondary aim:

Adverse effects if any

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with American society of anaestheslogist (ASA) score: I and II 2) Elective urological endoscopic surgery.
  • Duration of surgery not exceeding 45 min.

排除标准

  • Negative consent 2) Patients with ASA score III, IV 3) Body mass index (BMI) > 30 kg/m2 4) History of obstructive sleep apnoea 5) Anticipated difficult intubation 6) Spine deformities, previous spine surgery 7) Coagulation abnormalities 8) Allergy to local anaesthetics.

结局指标

主要结局

Effective sensory block ( onset and duration)

时间窗: Base line, 4 weeks, 8 weeks.

Effective motor block ( onset and duration)

时间窗: Base line, 4 weeks, 8 weeks.

Hemodynamic stability

时间窗: Base line, 4 weeks, 8 weeks.

次要结局

  • Adverse effects(Base line, 4 weeks, 8 weeks.)

研究者

发起方
GSVM
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

NEHA KUMAR

GSVM MEDICAL COLLEGE, KANPUR

研究点 (1)

Loading locations...

相似试验